Advertisement
Home »

Brigatinib Versus Alectinib in ALK-positive Non-small Cell Lung Cancer After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 Trial.

Aug 14, 2023

ABOUT THE EXPERTS

  • James Chih-Hsin Yang

    Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan.

    Geoffrey Liu

    Department of Medical Oncology, Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

    Shun Lu

    Shanghai Chest Hospital, Shanghai, China.

    Jianxing He

    Thoracic Cardio Surgery Department, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

    Mauricio Burotto

    Bradford Hill Clinical Research Center, Santiago, Chile.

    Myung-Ju Ahn

    Section of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

    Dong-Wan Kim

    Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea.

    XiaoQing Liu

    Fifth Medical Center of PLA General Hospital, Beijing, China.

    Yanqiu Zhao

    Affiliated Cancer Hospital of Zhengzhou University, Henan, China.

    Sylvie Vincent

    Oncology Cell Therapy Precision and Translational Medicine, Takeda Development Center Americas, Inc., Lexington, MA, USA.

    Jiani Yin

    Oncology Statistics, Takeda Development Center Americas, Inc., Lexington, MA, USA.

    Xin Ma

    Clinical Science, Takeda Development Center Americas, Inc., Lexington, MA, USA.

    Huamao M Lin

    Global Evidence and Outcomes Oncology, Takeda Development Center Americas, Inc., Lexington, MA, USA.

    Sanjay Popat

    Lung Unit, Royal Marsden Hospital, London, England, United Kingdom. Electronic address: sanjay.popat@rmh.nhs.uk.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement